Sort
21,453 grants matching “tuberculosis”
Targeting host immune cells and DAMP molecules to improve outcome in tuberculosis
$204,687William Ramses Bishai · Johns Hopkins University · R21 · FY2019 · AI
Inhibition of matrix degrading enzymes to limit cavitation in tuberculosis
$204,662William Ramses Bishai · Johns Hopkins University · R21 · FY2018 · AI
Core 3 Math Modeling Core
$204,650Michael N. Neely · University Of Florida · P01 · FY2024 · AI
Role of mycobacterial dynamin-like proteins in the biogenesis of membrane vesicles, and host-pathogen interactions
$204,637Gloria Marcela Rodriguez · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
Reducing the Burden of Road Traffic- Associated Mortality using Mobile Technology
$204,603Fiemu E Nwariaku · Ut Southwestern Medical Center · R21 · FY2020 · TW
Killed But Metabolically Active Leishmania: a novel protozoan vaccine technology
$204,600Noah A Craft · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R21 · FY2009 · AI
Functional Dissection of Toxin-Antitoxin Systems in Mycobacterium tuberculosis
$204,559Nancy Ann Woychik · Univ Of Med/Dent Nj-R W Johnson Med Sch · R21 · FY2010 · AI
Targeted Immunotherapy for Tuberculosis and HIV co-infection
$204,558William Ramses Bishai · Johns Hopkins University · R21 · FY2018 · AI
Comprehensive characterization of Rv0678 bedaquiline resistance-conferring polymorphisms
$204,479John Zapata Metcalfe · University Of California, San Francisco · R21 · FY2024 · AI
Stress-potentiated screening to identify novel inhibitors of M. tuberculosis
$204,450Robert N Husson · Boston Children'S Hospital · R21 · FY2013 · AI
Kaiser Washington Vaccine and Treatment Evaluation Unit
$204,442Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2022 · AI
Toolbox for Tuberculosis Drug Development
$204,375Johns Hopkins University · R01 · FY2003 · AI
Amyloid Precursor Proteins in Sarcoidosis
$204,375Johns Hopkins University · R21 · FY2005 · HL
Acquired susceptibility to pulmonary TB
$204,375Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R21 · FY2008 · AI
Decoding host-pathogen crosstalk that drives intracellular niche formation during Salmonella infection
$204,347Leigh Knodler · University Of Vermont & St Agric College · R21 · FY2025 · AI
SIV-specific Mamu-E-restricted CD8+ T cells
$204,339David I Watkins · University Of Wisconsin-Madison · R21 · FY2011 · AI
How do lysosomal disorders drive susceptibility to M.tb?
$204,323William Ramses Bishai · Johns Hopkins University · R21 · FY2017 · AI
Unraveling the link between serine/threonine protein kinase and two-component system regulation of environment-mediated Mycobacterium tuberculosis growth arrest
$204,300Shumin Tan · Tufts University Boston · R21 · FY2023 · AI
Understanding ischemia in children with tuberculous meningitis (iThemba)
$204,288James Alexander Seddon · Stellenbosch University · R01 · FY2025 · HD
Biosynthesis and transbilayer flipping of mycobacterial PIM glycolipids
$204,260Delphi Chatterjee · Colorado State University · R21 · FY2009 · AI
Targeting a New Essential Virulence Mechanism in Drug-Resistant Mycobacteria
$204,221Christina Leigh Stallings · Washington University · R21 · FY2015 · AI
INHIBITORS OF MYCOBACTERIAL ARABINOSYLTRANSFERASES
$204,204Ohio State University · R01 · FY2000 · AI
Macaque model of TB/AIDS co-infection via natural routes of exposure
$204,188Deepak Kaushal · Tulane University Of Louisiana · R21 · FY2010 · RR
Role of miRNA in lung damage during TB and TB/AIDS Co-infection
$204,188Deepak Kaushal · Tulane University Of Louisiana · R21 · FY2011 · AI
Elucidation of a novel mechanism of macrolide resistance in Mycobacterium abscessus
$204,155Pallavi Ghosh · Wadsworth Center · R21 · FY2020 · AI